Critical Heart Disease in Infants and Children
Mitral valve disease
Publication
, Chapter
Nellis, JR; Andersen, ND; Turek, JW
January 1, 2018
Congenital mitral valve disease is rarely seen in isolation. It is more commonly associated with complex congenital defects, including Shone’s complex, hypoplastic left heart syndrome, transposition of the great arteries, and connective tissue diseases. Symptoms vary based on the degree of obstruction or regurgitation. Obstructive pathologies are treated with diuretics and rhythm management, whereas insufficient pathologies depend on afterload reduction, inotropes, and diuretics. Operative intervention is indicated when medical management fails. Valve repair, not replacement, is the primary goal for congenital mitral valve disease based on the dynamic advantages it confers.
Duke Scholars
DOI
ISBN
9781455751006
Publication Date
January 1, 2018
Start / End Page
632 / 641.e2
Citation
APA
Chicago
ICMJE
MLA
NLM
Nellis, J. R., Andersen, N. D., & Turek, J. W. (2018). Mitral valve disease. In Critical Heart Disease in Infants and Children (pp. 632-641.e2). https://doi.org/10.1016/B978-1-4557-0760-7.00052-8
Nellis, J. R., N. D. Andersen, and J. W. Turek. “Mitral valve disease.” In Critical Heart Disease in Infants and Children, 632-641.e2, 2018. https://doi.org/10.1016/B978-1-4557-0760-7.00052-8.
Nellis JR, Andersen ND, Turek JW. Mitral valve disease. In: Critical Heart Disease in Infants and Children. 2018. p. 632-641.e2.
Nellis, J. R., et al. “Mitral valve disease.” Critical Heart Disease in Infants and Children, 2018, pp. 632-641.e2. Scopus, doi:10.1016/B978-1-4557-0760-7.00052-8.
Nellis JR, Andersen ND, Turek JW. Mitral valve disease. Critical Heart Disease in Infants and Children. 2018. p. 632-641.e2.
DOI
ISBN
9781455751006
Publication Date
January 1, 2018
Start / End Page
632 / 641.e2